Filing Details

Accession Number:
0000935836-24-000649
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-08 19:24:48
Reporting Period:
2024-11-06
Accepted Time:
2024-11-08 19:24:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819133 Tango Therapeutics Inc. TNGX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587114 Ecor1 Capital, Llc 357 Tehama Street #3
San Francisco CA 94103
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-11-06 1,494,558 $3.28 11,836,178 No 4 S Indirect See Note
Common Stock Disposition 2024-11-07 62,318 $3.29 11,773,860 No 4 S Indirect See Note
Common Stock Disposition 2024-11-07 1,143,124 $2.92 10,630,736 No 4 S Indirect See Note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Note
No 4 S Indirect See Note
No 4 S Indirect See Note
Footnotes
  1. The filers are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Qualified Fund and Mr. Nodelman. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim ownership of such securities except to the extent of their respective pecuniary interests therein.
  2. Qualified Fund sold 1,406,529 of the shares sold in this transaction.
  3. After this transaction, Qualified Fund held 11,156,852 shares of Issuer's Common Stock.
  4. Qualified Fund sold 58,647 of the shares sold in this transaction.
  5. After this transaction, Qualified Fund held 11,098,205 shares of Issuer's Common Stock.
  6. Qualified Fund sold 1,075,794 of the shares sold in this transaction.
  7. After this transaction, Qualified Fund held 10,022,411 shares of Issuer's Common Stock.